Percocet Dosage: A Clinician’s Guide to Oxycodone-Acetaminophen Strengths, Adult and Geriatric Dosing, Maximum Daily Limits, the Acetaminophen Ceiling, and Safe Use After Surgery

What the standard percocet dosage is for adults and older patients, the available tablet strengths and their oxycodone-acetaminophen combinations, the maximum daily acetaminophen dose that limits how much percocet can be taken safely, dosing in opioid-naive versus opioid-tolerant patients, dose adjustments for renal and hepatic impairment, and what to do when post-surgical percocet use has become more than occasional.

Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.

Percocet is a combination prescription opioid medication containing oxycodone and acetaminophen, available in tablet strengths of 2.5/325 mg, 5/325 mg, 7.5/325 mg, 7.5/500 mg, 10/325 mg, and 10/650 mg (oxycodone/acetaminophen). Standard adult dosing for acute pain is 1 to 2 tablets of the 5/325 mg strength every 4 to 6 hours as needed, with the dose taken with food to reduce gastrointestinal upset. The maximum daily acetaminophen dose for most adults is 3,000 to 4,000 mg, which limits total percocet dosing to no more than 8 tablets of the 5/325 mg strength or 9 tablets of the 10/325 mg strength per 24-hour period. Patients with chronic liver disease, regular heavy alcohol use, or hepatitis should not exceed 2,000 mg of acetaminophen per day. Opioid-naive patients should start with the lowest effective dose (2.5/325 mg or 5/325 mg every 4-6 hours), and dose escalation should be conservative. Older patients (65+) typically require 25-50 percent dose reduction. The medication carries a Schedule II controlled substance designation and a substantial risk of dependence with use beyond 5-7 days. Percocet use should generally be limited to the immediate post-surgical or acute injury period, with transition to non-opioid analgesics as the pain resolves.

What percocet is and the available dosages

Percocet is the brand name for a fixed-combination opioid analgesic containing oxycodone (a semi-synthetic opioid agonist) and acetaminophen (paracetamol). The medication was first approved by the FDA in 1976 as a Schedule II controlled substance and remains one of the most widely prescribed prescription opioid medications in the United States, with approximately 50 to 60 million prescriptions written annually before the prescribing curtailments that followed the recognition of the opioid crisis. Generic oxycodone-acetaminophen is available and is therapeutically equivalent to the branded Percocet product.

The available tablet strengths of Percocet and generic oxycodone-acetaminophen include 2.5 mg oxycodone with 325 mg acetaminophen, 5 mg with 325 mg, 7.5 mg with 325 mg, 7.5 mg with 500 mg, 10 mg with 325 mg, and 10 mg with 650 mg. The 5/325 mg formulation is the most commonly prescribed strength for adult post-surgical pain and acute injury. The higher oxycodone strengths (7.5 and 10 mg) are typically reserved for severe pain or for patients with established opioid tolerance. The 500 and 650 mg acetaminophen formulations have been largely phased out of prescribing because of acetaminophen overdose concerns, though some prescriptions still appear.

The combination of oxycodone with acetaminophen exploits two different analgesic mechanisms. Oxycodone is a mu opioid receptor agonist that works in the central nervous system to reduce pain perception and produce analgesia, with onset within 30 to 60 minutes after oral dosing and peak effect at 2 hours. Acetaminophen works through poorly understood central mechanisms, possibly including weak COX-3 inhibition and modulation of the endocannabinoid system, with onset within 30 to 60 minutes and peak effect at 1 to 2 hours. The combination provides somewhat better analgesia than either drug alone and has been a mainstay of moderate to severe pain management for nearly five decades.

Oral combination tablets are not the only formulation of oxycodone available. Oxycodone is also available as immediate-release single-ingredient tablets (Roxicodone) and as extended-release single-ingredient tablets (OxyContin) without acetaminophen. The combination products carry the additional constraint of acetaminophen dose ceiling, which limits how much oxycodone can be delivered through a Percocet prescription. This is one of the reasons that chronic pain patients sometimes transition from Percocet to single-ingredient oxycodone preparations: the acetaminophen ceiling caps the oxycodone dose at a level below what some patients need.

Standard adult dosing for acute pain

Standard adult dosing of Percocet for acute pain (post-surgical, traumatic injury, dental procedure, kidney stone) is 1 to 2 tablets of the 5/325 mg strength every 4 to 6 hours as needed, with the dose taken with food to reduce nausea and gastrointestinal upset. The medication should not be taken on a strict around-the-clock schedule for acute pain; the as-needed approach allows patients to take the medication when pain genuinely requires it and to skip doses when pain is controlled. Around-the-clock dosing is more appropriate for chronic pain management and for patients who consistently experience pain at predictable times.

The doctor prescribed dose should reflect the severity of pain, the patient’s opioid history, the expected duration of treatment, and the patient’s medical comorbidities. For moderate post-surgical pain in an opioid-naive adult patient, 1 tablet of 5/325 mg every 6 hours as needed is often sufficient, with the option to take 2 tablets if pain is severe. For more severe pain, 1 to 2 tablets every 4 hours as needed may be appropriate. The total daily dose should generally not exceed 6 tablets of 5/325 mg in opioid-naive patients without specific clinical reason and prescriber follow-up.

The duration of opioid prescribing for acute pain has been a focus of policy and clinical attention since the recognition of the opioid crisis in the mid-2010s. Current CDC and FDA guidance recommends limiting initial opioid prescriptions for acute pain to the shortest duration necessary, typically 3 to 7 days. Many state laws now restrict initial opioid prescriptions to 5 to 7 days for acute pain without re-evaluation. The change reflects the recognition that opioid dependence can develop within 5 to 7 days of regular use even in opioid-naive patients, and that the risk of progression to long-term use is dose- and duration-dependent.

Patients should take the medication only as long as the acute pain requires opioid analgesia, with transition to non-opioid alternatives (acetaminophen alone, NSAIDs if not contraindicated, ice, rest, physical therapy) as soon as the pain allows. Many patients can transition from Percocet to acetaminophen or ibuprofen by day 3 to 5 after most outpatient surgical procedures. The decision to extend opioid prescribing beyond the initial week should involve a clinical visit and reassessment of the pain, not a routine refill request.

The acetaminophen ceiling and why it matters

The acetaminophen component of Percocet imposes a strict ceiling on how much of the medication can be taken safely. Acetaminophen has a narrow therapeutic index, with a maximum daily dose of 4,000 mg for most healthy adults; doses above this threshold can produce acute liver injury, and doses above 7,000 mg in a 24-hour period can cause fulminant hepatic failure and death. The acetaminophen content of Percocet thus directly limits how many tablets can be taken in a 24-hour period: at 325 mg acetaminophen per tablet, the maximum is approximately 12 tablets per day, though most clinical guidance recommends a lower ceiling of 3,000 mg per day for safety margin, which translates to 9 tablets per day.

The acetaminophen ceiling becomes more restrictive in several populations. Patients with chronic liver disease, hepatitis, cirrhosis, or other hepatic impairment should not exceed 2,000 mg of acetaminophen per day, which limits Percocet to 6 tablets per day. Patients who consume more than 3 alcoholic drinks per day on average should similarly limit acetaminophen to 2,000 mg per day because of the synergistic hepatotoxicity. Elderly patients with reduced hepatic function and patients with severe malnutrition have similarly reduced ceilings. The acetaminophen ceiling may be the limiting factor on the analgesia that Percocet can safely provide in these patients.

Acetaminophen overdose is a leading cause of acute liver failure in the United States and is one of the principal hazards of opioid-acetaminophen combinations. The overdose can occur unintentionally when patients take Percocet plus additional acetaminophen from over-the-counter products (Tylenol, cold medications, sleep aids containing acetaminophen) without realising the combined exposure. The 2014 FDA limit on the acetaminophen content of combination prescription products to 325 mg per tablet was a direct response to this risk, replacing the older 500 mg and 650 mg formulations that produced more unintentional overdoses.

Patients on Percocet should be specifically counselled about acetaminophen-containing over-the-counter medications. The pharmacist or prescriber should provide a list of common products to avoid, including Tylenol, Tylenol PM, Excedrin, NyQuil, DayQuil, Theraflu, Vick’s Formula 44, many sleep aids, and many cold and cough medications. Patients should be told to read the labels of any new medication and to check with the pharmacist before adding any over-the-counter product to their regimen while on Percocet. The acetaminophen ceiling protects the patient only if the patient is counting all sources of acetaminophen in their daily intake.

Dosing for opioid-tolerant patients

Patients who have been on long-term opioid therapy or who have established opioid tolerance from prior use require different dosing than opioid-naive patients. Tolerance develops with chronic opioid use as the brain adapts to the persistent receptor activation, and the dose required to produce the same analgesic effect rises substantially over months to years of treatment. A patient who has been on long-term opioid therapy for chronic pain may require 30 to 60 mg of oxycodone daily, equivalent to 6 to 12 tablets of 5/325 mg Percocet, plus the acetaminophen ceiling considerations that come with it.

For opioid-tolerant patients, conversion from other opioid medications to Percocet uses standard equianalgesic dosing tables. 30 mg of morphine is approximately equivalent to 20 mg of oxycodone or 4 tablets of 5/325 mg Percocet. The conversion is approximate and individual patient response varies; the standard approach is to convert to 50 to 75 percent of the equianalgesic dose initially and titrate based on response and side effects. The acetaminophen ceiling often makes Percocet impractical for high-dose chronic opioid therapy, and single-ingredient oxycodone formulations are typically preferred at those dose levels.

Patients in cancer pain management may use Percocet as a breakthrough analgesic on top of a baseline long-acting opioid such as extended-release oxycodone or extended-release morphine. The breakthrough Percocet doses are typically 10 to 20 percent of the daily long-acting opioid dose, given every 1 to 2 hours as needed. The acetaminophen content still limits total daily Percocet use, and many cancer pain patients transition to single-ingredient oxycodone immediate-release tablets for breakthrough pain when the cumulative acetaminophen would exceed the ceiling.

Patients with established opioid use disorder who are on medication-assisted treatment with methadone or buprenorphine present a more complex situation. Acute pain treatment in these patients should generally not use Percocet or other partial opioid agonists; the patient is already receiving substantial opioid receptor activation from the medication-assisted treatment, and acute additional opioid analgesia requires specific protocols developed with their addiction medicine specialist. The general approach is to use non-opioid analgesia where possible, to involve the addiction medicine team in the acute pain plan, and to use short-acting opioids for severe acute pain with careful monitoring.

Special populations and dose adjustments

Older patients (over 65 years) typically require dose reduction of 25 to 50 percent compared to younger adults. The reasons include reduced hepatic clearance of both oxycodone and acetaminophen, increased sensitivity to opioid effects including respiratory depression and confusion, increased risk of falls, and the polypharmacy typical in this age group. Starting doses in older patients should be 2.5/325 mg every 6 hours as needed rather than the 5/325 mg every 4-6 hours typical for younger adults, with conservative titration based on pain control and side effects.

Patients with hepatic impairment require dose reduction for both components. Oxycodone is metabolised by CYP3A4 and CYP2D6 in the liver, with reduced clearance in hepatic dysfunction producing higher plasma levels at standard doses. Acetaminophen is metabolised by the liver and the metabolites that produce hepatotoxicity accumulate at higher levels in hepatic impairment. Patients with Child-Pugh class B or C cirrhosis should generally avoid acetaminophen-containing combination products and should use single-ingredient opioids if opioid analgesia is required.

Patients with renal impairment require attention to the active metabolites of oxycodone. Oxycodone itself is metabolised to oxymorphone (more potent than oxycodone) and noroxycodone, both of which are renally excreted. Severe renal impairment (eGFR less than 30 mL/min) produces accumulation of these metabolites and increased risk of respiratory depression and prolonged sedation. Dose reduction or use of an alternative opioid (morphine produces problematic metabolites in renal failure also, but hydromorphone has fewer renally excreted active metabolites) may be appropriate.

Patients with chronic obstructive pulmonary disease, obstructive sleep apnoea, or severe heart failure are at elevated risk of respiratory depression and should receive dose reduction and intensified monitoring. Pregnant women should avoid Percocet except when clearly necessary and at the lowest effective dose for the shortest duration. The medication crosses the placenta and is excreted in breast milk; neonatal abstinence syndrome can occur in newborns of mothers who took opioids during pregnancy.

Common side effects of percocet

The most common side effects of Percocet are typical of opioid analgesics generally. Constipation is essentially universal with regular use and is one of the most underappreciated effects; patients should be told to take stool softeners or laxatives prophylactically if Percocet use extends beyond a few days. Nausea and vomiting are common in the first few days, particularly in opioid-naive patients, and usually improve with continued use or with anti-emetic medication. Drowsiness, dizziness, lightheadedness, and reduced mental sharpness are dose-related and improve with tolerance. Itching is common and is usually due to opioid-induced histamine release rather than allergy.

Less common but more serious side effects include respiratory depression (particularly at high doses or in combination with other CNS depressants), urinary retention, paradoxical hyperalgesia with chronic use, opioid-induced bowel dysfunction including chronic constipation and ileus, hypogonadism with chronic use, and immune effects with chronic high-dose use. Allergic reactions including rash, urticaria, and rarely anaphylaxis can occur, and patients with documented oxycodone allergy should not receive any oxycodone-containing product.

Cardiovascular effects of Percocet include orthostatic hypotension and reduced heart rate, particularly in older patients and those on antihypertensive medications. Patients should be cautioned about getting up slowly from sitting or lying positions during the first few days of treatment. Falls related to orthostatic hypotension and to opioid-induced sedation are a leading cause of injury in older patients on Percocet, and fall prevention strategies should be part of the prescribing conversation.

Dependence and addiction are the most concerning long-term effects of Percocet use. Physical dependence develops with daily use beyond 5 to 7 days, with abrupt discontinuation producing withdrawal symptoms including anxiety, restlessness, sweating, gastrointestinal upset, muscle pain, and craving. Addiction (compulsive use, continued use despite consequences, craving, loss of control) develops in a substantial minority of patients exposed to opioids for extended periods. The risk is highest in patients with prior substance use disorders, mental health comorbidity, family history of addiction, and certain genetic factors.

Overdose and the role of naloxone

Percocet overdose is one of the more common scenarios for accidental opioid overdose because the medication is widely available, can be inadvertently overdosed when patients combine it with other opioid products or with acetaminophen-containing products, and can produce both opioid toxicity (respiratory depression, profound sedation) and acetaminophen toxicity (hepatic injury, fulminant liver failure). The two toxicity profiles have different timelines: opioid toxicity manifests within hours of the overdose, while acetaminophen hepatotoxicity may not be clinically apparent until 24 to 72 hours later when liver injury becomes severe.

Opioid overdose symptoms include profound sedation progressing to unresponsiveness, slow and shallow breathing, blue or grey colour around the lips and fingertips, pinpoint pupils, and unresponsiveness to verbal and physical stimulation. Anyone with these symptoms requires immediate emergency medical evaluation. Naloxone (Narcan) is the opioid antagonist that reverses opioid overdose and is now widely available without prescription at most US pharmacies. Patients on Percocet should consider keeping naloxone in their home, particularly if they live with others who may need to administer it, and any household member who can recognise opioid overdose should know how to use naloxone.

Acetaminophen overdose treatment uses N-acetylcysteine, the antidote that protects against hepatic injury when given within the first 8 to 10 hours of ingestion. Patients with Percocet overdose require both naloxone for the opioid component and N-acetylcysteine for the acetaminophen component, plus supportive care for any organ dysfunction. The emergency department treatment of mixed opioid-acetaminophen overdose can be complex and requires evaluation of both compounds.

Combining Percocet with other substances substantially elevates overdose risk. Alcohol is the most common combination and produces both additional respiratory depression and additional hepatotoxicity from the alcohol effect on liver metabolism. Benzodiazepines produce additive respiratory depression and were the basis for the 2016 FDA boxed warning. Other opioids (including illicit fentanyl, heroin, or additional prescription opioids) substantially raise the dose and the overdose risk. Patients on Percocet should not combine the medication with any other sedating substance without explicit prescriber approval.

Tapering off percocet

Patients who have been on Percocet for more than 5 to 7 days may experience mild withdrawal symptoms when they stop. The withdrawal is generally mild compared to that of long-term opioid use and includes anxiety, restlessness, mild gastrointestinal upset, muscle aches, and craving. Most patients can stop Percocet abruptly after short-term use for acute pain without significant withdrawal, but patients who have used the medication for 2 weeks or more often benefit from a brief taper over 3 to 7 days, reducing the dose by 25 to 50 percent every 1 to 2 days.

Patients who have been on Percocet for months should taper more slowly under prescriber guidance. The taper typically involves reducing the daily dose by 10 to 20 percent every week to two weeks, with attention to withdrawal symptoms and to whether the underlying pain is being adequately managed. Adjunct medications during the taper can include non-opioid analgesics for any breakthrough pain, clonidine for autonomic symptoms, and sleep medications for transient insomnia. The taper is usually manageable in the outpatient setting with regular clinical contact.

Patients who have developed problematic use patterns (taking more than prescribed, seeking early refills, doctor shopping, using Percocet from non-medical sources) may have developed opioid use disorder and benefit from addiction medicine assessment rather than simple taper. The diagnostic criteria for opioid use disorder include impaired control over use, continued use despite consequences, tolerance, withdrawal, and craving. Patients meeting these criteria should be evaluated for medication-assisted treatment with buprenorphine or methadone, which substantially improves outcomes compared to taper alone.

The transition from acute Percocet use to ongoing opioid use disorder is one of the more common pathways into the prescription opioid crisis. The patient who was prescribed Percocet after surgery and continued using long after the pain had resolved, who escalated doses, who began obtaining the medication from multiple prescribers or from illicit sources, is the prototypical pathway to addiction. The Phuket Island Rehab residential program provides addiction medicine treatment for prescription opioid use disorder, including medical detoxification, medication-assisted treatment, and structured therapy.

When percocet use and drinking have become more than occasional

For readers who have been on Percocet for months and recognise that the use has continued beyond the original acute pain, the situation often involves both ongoing prescription medication use and patterns of alcohol use that have developed alongside it. Many patients who continue Percocet long after the original injury also drink in patterns that they have not connected to their opioid use; the combination of regular Percocet and regular drinking is dangerous and is one of the more common patterns in prescription opioid-related overdose.

Heavy drinking on top of Percocet produces several compounding problems. The respiratory depression of both substances combines and substantially increases the overdose risk. The hepatotoxicity of acetaminophen is amplified by alcohol, particularly in chronic drinkers, and patients who take Percocet plus regular alcohol consumption are at elevated risk of acute liver injury from doses that would not produce harm in non-drinkers. The cognitive impairment from both substances produces substantial functional impairment that the patient often does not recognise.

Alcohol use disorder, the clinical term for problematic alcohol use, is defined by the DSM-5 criteria including drinking more than intended, unsuccessful efforts to cut down, craving, tolerance, withdrawal, and continued use despite consequences. Many patients on long-term Percocet also meet AUD criteria. Phuket Island Rehab provides residential addiction medicine treatment for opioid use disorder, alcohol use disorder, and dual diagnosis cases that include co-occurring chronic pain, anxiety, depression, or other mental health conditions.

Summary

Percocet is the brand name for oxycodone-acetaminophen combination tablets available in strengths of 2.5/325, 5/325, 7.5/325, 7.5/500, 10/325, and 10/650 mg. Standard adult dosing for acute pain is 1 to 2 tablets of the 5/325 mg strength every 4 to 6 hours as needed, with the dose taken with food. The acetaminophen ceiling limits total daily Percocet dosing, with most adults not exceeding 3,000 to 4,000 mg of acetaminophen and patients with hepatic impairment or chronic alcohol use limited to 2,000 mg. Older patients require 25 to 50 percent dose reduction. Common side effects include constipation, nausea, drowsiness, dizziness, and itching. Serious effects include respiratory depression at high doses or with CNS depressant combinations, hepatic injury from acetaminophen overdose, and dependence with use beyond 5 to 7 days. The medication should generally be limited to the immediate post-surgical or acute injury period, with transition to non-opioid analgesics as the pain resolves. Patients who have developed dependence or addiction patterns benefit from addiction medicine assessment and medication-assisted treatment. As Dr. Ponlawat Pitsuwan summarises, “Percocet is a useful medication for acute moderate to severe pain when prescribed and used for short courses. The same medication used for months after the original pain has resolved often produces dependence that the patient did not anticipate, and treatment is more straightforward when started early.”

Frequently asked questions

What is the standard percocet dosage?

Standard adult dosing for acute pain is 1 to 2 tablets of the 5/325 mg strength every 4 to 6 hours as needed, with the medication taken with food. The maximum daily dose is limited by the acetaminophen content, typically not exceeding 8 to 9 tablets per day. Older patients require dose reduction of 25 to 50 percent.

How much percocet can I take in 24 hours?

The maximum is limited by the acetaminophen content, with most adults not exceeding 3,000 to 4,000 mg of acetaminophen per day. For 5/325 mg tablets, this translates to 9 to 12 tablets per day maximum, though clinical practice typically caps at 8 tablets per day for safety margin. Patients with hepatic impairment, chronic alcohol use, or hepatitis should not exceed 2,000 mg of acetaminophen per day.

Can I take percocet with other pain medications?

Combining Percocet with non-opioid analgesics is generally safe and often appropriate. Ibuprofen, naproxen, or acetaminophen alone can be taken with Percocet, though the acetaminophen content must be added to the Percocet acetaminophen for total daily dose calculations. Combining Percocet with other opioid medications is dangerous and should only be done under specific prescriber guidance.

What is the strongest percocet dose?

The highest available oxycodone-acetaminophen combination is 10 mg oxycodone with 650 mg acetaminophen (10/650), though this formulation has been largely phased out. The 10/325 mg formulation remains widely available. For very severe pain, single-ingredient oxycodone immediate-release tablets (Roxicodone) at 15, 20, or 30 mg per tablet can be prescribed; these formulations remove the acetaminophen ceiling but still require careful dosing.

How long can I take percocet?

Current guidelines recommend limiting initial opioid prescriptions for acute pain to 3 to 7 days, with re-evaluation before any extension. Use beyond 7 to 10 days substantially increases the risk of dependence. Chronic Percocet use for long-term pain management is rarely appropriate; transition to non-opioid analgesics or to a chronic pain treatment plan with appropriate specialist involvement is preferred.

Can I drink alcohol with percocet?

No. The combination of Percocet and alcohol substantially increases respiratory depression risk, amplifies the hepatotoxicity of acetaminophen, produces additive cognitive impairment, and significantly raises overdose risk. Patients on Percocet should avoid alcohol entirely during the treatment period and should not return to drinking until at least 24 hours after the last dose.

Sources

• U.S. Food and Drug Administration (FDA). Percocet (oxycodone and acetaminophen) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/040330s015,040341s013,040434s003lbl.pdf
• Centers for Disease Control and Prevention (CDC). CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
• U.S. Food and Drug Administration (FDA). Acetaminophen safety. https://www.fda.gov/drugs/information-drug-class/acetaminophen-information
• U.S. Food and Drug Administration (FDA). Boxed warning on opioid and benzodiazepine combination. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
• National Institute on Drug Abuse (NIDA). Prescription Opioids DrugFacts. https://nida.nih.gov/publications/drugfacts/prescription-opioids
• American Society of Addiction Medicine (ASAM). National Practice Guideline for the Treatment of Opioid Use Disorder. https://www.asam.org/quality-care/clinical-guidelines/national-practice-guideline
• Substance Abuse and Mental Health Services Administration (SAMHSA). Medications for Opioid Use Disorder. https://www.samhsa.gov/medications-substance-use-disorders

percocet dosage, percocet, oxycodone, acetaminophen, oxycodone-acetaminophen, paracetamol, opioid, semi-synthetic opioid, mu opioid receptor, opioid agonist, opioid analgesic, prescription opioid, Schedule II controlled substance, FDA, CDC, NIDA, SAMHSA, ASAM, hepatotoxicity, acetaminophen overdose, acute liver failure, fulminant hepatic failure, Roxicodone, OxyContin, immediate-release, extended-release, tablet, strength, 5/325 mg, 10/325 mg, 7.5/325 mg, 2.5/325 mg, 500 mg, 650 mg, 325 mg, opioid, take, side, drug, medications, doctor, addiction, prescribed, cause, liver, overdose, taking, available, hours, help, dose, dosing, maximum daily dose, dose adjustment, opioid-naive, opioid-tolerant, equianalgesic dosing, acetaminophen ceiling, 4000 mg, 3000 mg, 2000 mg, older adults, elderly, geriatric, renal impairment, hepatic impairment, Child-Pugh, COPD, sleep apnoea, pregnancy, neonatal abstinence syndrome, side effects, constipation, nausea, vomiting, drowsiness, dizziness, itching, urinary retention, hyperalgesia, hypogonadism, allergic reaction, respiratory depression, opioid overdose, naloxone, Narcan, N-acetylcysteine, dependence, addiction, opioid use disorder, OUD, withdrawal, taper, medication-assisted treatment, MAT, methadone, buprenorphine, alcohol, alcohol use disorder, AUD, polysubstance use, DSM-5, dual diagnosis, NIDA, FDA, CDC, SAMHSA, NHS 111, Phuket Island Rehab, addiction medicine, prescription drug abuse.